Biologic characteristics of interval and screen-detected breast cancers

Citation
Fd. Gilliland et al., Biologic characteristics of interval and screen-detected breast cancers, J NAT CANC, 92(9), 2000, pp. 743-749
Citations number
62
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Volume
92
Issue
9
Year of publication
2000
Pages
743 - 749
Database
ISI
SICI code
Abstract
Background: Interval breast cancer is defined as a cancer that is detected within 12 months after a negative mammogram. The failure of mammography to detect breast cancer depends on testing procedures, radiologist interpretat ion, patient characteristics, and tumor properties. Although errors by radi ologists explain some interval cancers, another explanation is that the tum or is rapidly growing and was too small to be detected on the last mammogra m. To determine whether markers of tumor growth rate are associated with ri sk of an interval cancer, we conducted a population-based study with the us e of data collected statewide by the New Mexico Mammography Project. Method s: Among women who received a mammographic examination from 1991 throughout 1993, we ascertained records of all patients with breast cancer diagnosed within 12 months of a negative screening mammographic examination (interval cancers) and corresponding tumor samples, when available. We selected an a ge- and ethnicity-matched comparison group of control patients with screen- detected breast cancers diagnosed during the same period. In tumor samples, p53, bcl-2, and Ki-67 were examined immunologically and the apoptotic inde x was assessed histologically. We used logistic regression to determine whe ther interval cancers were associated with selected demographic, radiologic , and biologic characteristics. Results: It is more likely that mammography did not detect tumors with a high proportion of proliferating cells (>20%) than tumors with a low proportion of proliferating cells (<5%) (odds ratio [OR] = 4.09; 95% confidence interval [CI] = 1.14-14.65). The OR for mammog raphic failure was 2.96 (95% CI = 1.07-8.20) among cancers that expressed p 53 compared with cancers that did not. Interval cancers also had fewer apop totic cells. Approximately 75% of interval cancers appear to have tumors wi th 5% proliferating cells or more. Younger women had a higher proportion of rapidly proliferating and aggressive cancers. Conclusion: Rapidly growing and aggressive tumors account for a substantial proportion of mammographic failure to detect breast cancer, especially among younger women, who have a high proportion of aggressive cancers.